This page was automatically translated and accurateness of translation is not guaranteed. Please refer to the English version for a source text.

3D ECG for Detection of Cardiomyopathy

3D ECG for Detection of Cardiomyopathy in Heart Failure

스폰서

리드 스폰서: University Hospital, Essen

출처 University Hospital, Essen
간단한 요약

There is existing data in the literature that suggests an additional predictive value of three dimensional ECG with respect to the presence of electrical abnormalities and for an existing cardiac disease. Especially regarding patients who suffered from a myocardial infarction in the past (post MI patients), evidence has been provided for a potential association of 3D repolarisation abnormalities and incidence of sudden cardiac death (SCD). In addition, there is some vague evidence of so called 3D ECG and prediction of coronary artery disease. This 3D ECG device is using the technology of 3D ECG vector loops and is assessing the variability of these ECG vector loops in the 3-dimensional space. Based on these data, the parameters of 3D ECG are suggested to carry certain value to predict or to identify individuals already suffering from a cardiac disease or being at risk experiencing a cardiac event in the future. In this context we performed a preliminary study with 3D-ECG device in healthy volunteers evaluating the robustness of this method with respect to reproducibility, intra- and intra-observer variability which could be confirmed. We thus postulate that the 3D ECG technology might bear the potential to serve as a sufficient screening method for diagnosing cardiomyopathy in patients with an unknown heart failure etiology.

전반적인 상태 Recruiting
시작일 2021-03-14
완료 날짜 2021-10-14
기본 완료 날짜 2021-09-14
연구 유형 Observational
주요 결과
법안 시간 프레임
Cardiomyopathy Within 24 hours
등록 175
질환
개입

개입 유형: Diagnostic Test

개입 이름: 3D-ECG

기술: Patient recieves 3D-ECG Assessement

팔 그룹 레이블: Patient recieving 3D-ECG-Evaluation

적임

샘플링 방법:

Probability Sample

기준:

Inclusion Criteria: - Age >18 Years - Established diagnosis heart failure and suggested cardiomyopathy Exclusion Criteria: - Patients unable to sign informed consent - Pacemaker-stimulated ECG

성별:

All

최소 연령:

18 Years

최대 연령:

N/A

건강한 자원 봉사자:

No

전체 공식
성 역할 입회
Reza Wakili, Prof. Principal Investigator University Hospital, Essen
전반적인 연락처

성: Reza Wakili, Prof.

전화: 00492017234802

이메일: reza.wakili@uk-essen.de

위치
시설: 상태: 접촉: 연락처 백업: West-German Heart and Vascular Center Essen, University Hospital Essen Reza Wakili, Prof. Dr. 0201 723 4802 reza.wakili@uk-essen.de
위치 국가

Germany

확인 날짜

2021-04-01

책임있는 당사자

유형: Sponsor

확장 된 액세스 있음 No
조건 찾아보기
팔 그룹

상표: Patient recieving 3D-ECG-Evaluation

환자 데이터 No
연구 설계 정보

관찰 모델: Cohort

시간 관점: Prospective

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

analytics

Heart Failure에 대한 임상 시험

구독하다